Innovate Biopharmaceuticals Plans to Commence the First Ever Phase 3 Registration Trial in Celiac Disease Pharmaceutical Investing
Atara Biotherapeutics Presents Positive Efficacy and Safety Results for Patients with Epstein-Barr Virus-Associated Leiomyosarcoma Pharmaceutical Investing
Life Science Big News Roundup: NanoSphere Forms Strategic Partnership in Mexico; Chemesis International Inc. Announces Approval of OTCQB Uplisting Life Science Investing
Green Growth Brands to Acquire Option for Medical and Retail Dispensary in Henderson, Nevada Cannabis Investing News
Isodiol International Inc. Announces the Appointment of Dr. Gerry Ramogida to the ISO-SPORT™ Medical Advisory Board Cannabis Investing News
Aptevo Therapeutics Doses First Patient in Phase 1/1b Clinical Trial of Lead Next-Generation Bispecific Antibody APVO436 Biotech Investing
